These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 813573)

  • 21. Comparison of the in vitro activity of several cephalosporin antibiotics against gram-negative and gram-positive bacteria resistant to cephaloridine.
    Kisch AL; Bartholomew L
    Antimicrob Agents Chemother; 1976 Sep; 10(3):507-10. PubMed ID: 984793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of BMY 28100, a new oral cephalosporin.
    Steele J; Edwards B; Rissing J
    Eur J Clin Microbiol; 1987 Feb; 6(1):111-3. PubMed ID: 3494601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion disk susceptibility testing with cefotaxime.
    Aswapokee N; Aswapokee P; Neu HC; Fu KP
    Antimicrob Agents Chemother; 1979 Aug; 16(2):164-6. PubMed ID: 114106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin.
    Blandino G; Dubini F; Russo G; Cocuzza G
    Clin Ther; 1980; 3(Spec Issue):103-11. PubMed ID: 6446383
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.
    Katsu K; Kitoh K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Aug; 22(2):181-5. PubMed ID: 6100421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin].
    Chantot JF; Bryskier A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):482-6. PubMed ID: 3937124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, including beta-lactamase producers.
    Wiedemann B; Luhmer E; Zühlsdorf MT
    Infection; 1991; 19(5):363-9. PubMed ID: 1800378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergism between cefazedone and gentamicin in vitro.
    Rudolph V; Reuss K
    Arzneimittelforschung; 1979; 29(2a):396-400. PubMed ID: 114188
    [No Abstract]   [Full Text] [Related]  

  • 29. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
    Garcia-Rodriguez JA
    Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canadian Multicenter Susceptibility Study, with a focus on cephalosporins, from 15 Canadian medical centers. The Canadian Multicenter Study Group.
    Blondeau JM; Yaschuk Y
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2773-5. PubMed ID: 9420058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro evaluation of cefpimizole (U-63196E), a new antipseudomonal cephalosporin.
    LeFrock JL; Smith BR; Bihl J
    Antimicrob Agents Chemother; 1985 Jul; 28(1):133-7. PubMed ID: 3929676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro activity of BMY-28142, a new cephalosporin.
    Norden CW; Neiderriter K
    Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
    Baumgartner JD; Glauser MP
    Eur J Clin Microbiol; 1983 Oct; 2(5):501-4. PubMed ID: 6315426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Haemophilus influenzae type b to cefatrizine, ampicillin, and chloramphenicol.
    Brotherton T; Lees T; Feigin RD
    Antimicrob Agents Chemother; 1976 Aug; 10(2):322-4. PubMed ID: 1086634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro activity of BMY 28142, a new aminothiazolyl cephalosporin.
    Steele JC; Edwards BH; Rissing JP
    J Antimicrob Chemother; 1985 Oct; 16(4):463-8. PubMed ID: 3840799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro effects of cephalexin monohydrate on 1,398 bacterial isolations of various genuses].
    Gonzalez S; Hill JM; Luna M; Gutierrez M; Garcia M; Escarzaga Tapia E
    Prensa Med Mex; 1970; ():11-5. PubMed ID: 4996099
    [No Abstract]   [Full Text] [Related]  

  • 39. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus.
    Olarte J
    Clin Ther; 1980; 3(Spec Issue):130-3. PubMed ID: 6446386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.